Melatonin enhances endogenous heme oxygenase-1 and represses immune responses to ameliorate experimental murine membranous nephropathy

Journal of Pineal Research

Volumn 52, Issue 4, 2012, Pages 460-469

  Wu, Chia Chao ^a,b   Lu, Kuo Cheng ^c   Lin, Gu Jiun ^b   Hsieh, Hsin Yi ^b   Chu, Pauling ^a   Lin, Shih Hua ^a   Sytwu, Huey Kang ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

apoptosis; heme oxygenase 1; immunomodulation; melatonin; membranous nephropathy

Indexed keywords

ANTIOXIDANT; BOVINE SERUM ALBUMIN; CELL MARKER; CYTOKINE; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; INTERLEUKIN 10; MELATONIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; ENZYME BLOOD LEVEL; ENZYME INDUCTION; FEMALE; HISTOPATHOLOGY; IDIOPATHIC DISEASE; IMMUNE RESPONSE; IMMUNOMODULATION; KIDNEY INJURY; MEMBRANOUS GLOMERULONEPHRITIS; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; PROTEIN EXPRESSION; PROTEINURIA; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; APOPTOSIS; CATTLE; CYTOKINES; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HEME OXYGENASE-1; HISTOCYTOCHEMISTRY; KIDNEY; LYMPHOCYTES; MELATONIN; MICE; MICE, INBRED BALB C; PROTECTIVE AGENTS; SERUM ALBUMIN, BOVINE;

EID: 84862825938     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00960.x     Document Type: Article

References (44)

1. Ronco P, Debiec H,. New insights into the pathogenesis of membranous glomerulonephritis. Curr Opin Nephrol Hypertens 2006; 15: 258-263.
2. Cunningham PN, Quigg RJ,. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol 2005; 16: 1214-1222.
3. Nangaku M, Shankland SJ, Couser WG,. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 2005; 16: 1195-1204.
4. Cattran D,. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol 2005; 16: 1188-1194.
5. Glassock RJ,. The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum? Am J Kidney Dis 2004; 44: 562-566.
6. Stehle JH, Saade A, Rawashdeh O, et al., A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011; 51: 17-43.
7. Jung-Hynes B, Reiter RJ, Ahmad N,. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 2010; 48: 9-19.
8. Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM,. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310.
9. Reiter RJ,. The melatonin rhythm: both a clock and a calendar. Experientia 1993; 49: 654-664.
10. Malpaux B, Migaud M, Tricoire H, Chemineau P,. Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin. J Biol Rhythms 2001; 16: 336-347.
11. Rodriguez C, Mayo JC, Sainz RM, et al., Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
12. Jou MJ, Peng TI, Hsu LF, et al., Visualization of melatonin's multiple mitochondrial levels of protection against mitochondrial Ca(2+)-mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res 2010; 48: 20-38.
13. Bonnefont-Rousselot D, Collin F, Jore D, Gardes-Albert M,. Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. J Pineal Res 2011; 50: 328-335.
14. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
15. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ,. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200.
16. Belyaev O, Herzog T, Munding J, et al., Protective role of endogenous melatonin in the early course of human acute pancreatitis. J Pineal Res 2011; 50: 71-77.
17. Currier NL, Sun LZ, Miller SC,. Exogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity. J Neuroimmunol 2000; 104: 101-108.
18. Raghavendra V, Singh V, Kulkarni SK, Agrewala JN,. Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem 2001; 221: 57-62.
19. Raghavendra V, Singh V, Shaji AV, Vohra H, Kulkarni SK, Agrewala JN,. Melatonin provides signal 3 to unprimed CD4(+) T cells but failed to stimulate LPS primed B cells. Clin Exp Immunol 2001; 124: 414-422.
20. Shaji AV, Kulkarni SK, Agrewala JN,. Regulation of secretion of IL-4 and IgG1 isotype by melatonin-stimulated ovalbumin-specific T cells. Clin Exp Immunol 1998; 111: 181-185.
21. Chen JS, Chen A, Chang LC, et al., Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrol Dial Transplant 2004; 19: 2721-2728.
22. Wu CC, Chen JS, Chen SJ, et al., Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy. Kidney Int 2007; 72: 831-840.
23. Wu CC, Chen JS, Lin SH, Chen A, Sytwu HK, Lin YF,. Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events. Lab Anim 2008; 42: 350-359.
24. Lefaucheur C, Stengel B, Nochy D, et al., Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 2006; 70: 1510-1517.
25. Mercadal L, Montcel ST, Nochy D, et al., Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 2002; 17: 1771-1778.
26. Brasen JH, Nieminen-Kelha M, Markmann D, et al., Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1)-mediated pathway and vascular oxidative injury in older-age rat renal transplants. Kidney Int 2005; 67: 1583-1594.
27. Radogna F, Diederich M, Ghibelli L,. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 2010; 80: 1844-1852.
28. Carrillo-Vico A, Reiter RJ, Lardone PJ, et al., The modulatory role of melatonin on immune responsiveness. Curr Opin Investig Drugs 2006; 7: 423-431.
29. Da SC-M, Carvalho-Sousa CE, Tamura EK, et al., TLR4 and CD14 receptors expressed in rat pineal gland trigger NFKB pathway. J Pineal Res 2010; 49: 183-192.
30. Markus RP, Ferreira ZS, Fernandes PA, Cecon E,. The immune-pineal axis: a shuttle between endocrine and paracrine melatonin sources. Neuroimmunomodulation 2007; 14: 126-133.
31. Lin GJ, Huang SH, Chen YW, et al., Melatonin prolongs islet graft survival in diabetic NOD mice. J Pineal Res 2009; 47: 284-292.
32. Cernysiov V, Gerasimcik N, Mauricas M, Girkontaite I,. Regulation of T-cell-independent and T-cell-dependent antibody production by circadian rhythm and melatonin. Int Immunol 2010; 22: 25-34.
33. Kim CH, Kim KH, Yoo YM,. Melatonin protects against apoptotic and autophagic cell death in C2C12 murine myoblast cells. J Pineal Res 2011; 50: 241-249.
34. Da Silva CM, Ias-Garcia B, Miro-Moran A, et al., Melatonin reduces lipid peroxidation and apoptotic-like changes in stallion spermatozoa. J Pineal Res 2011; 51: 172-179.
35. Neale TJ, Ojha PP, Exner M, et al., Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J Clin Invest 1994; 94: 1577-1584.
36. Naji L, Carrillo-Vico A, Guerrero JM, Calvo JR,. Expression of membrane and nuclear melatonin receptors in mouse peripheral organs. Life Sci 2004; 74: 2227-2236.
37. Song Y, Ayre EA, Pang SF,. [125I]iodomelatonin binding sites in mammalian and avian kidneys. Biol Signals 1993; 2: 207-220.
38. Carrillo-Vico A, Lardone PJ, Naji L, et al., Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J Pineal Res 2005; 39: 400-408.
39. Nath KA,. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 2006; 70: 432-443.
40. Ryter SW, Alam J, Choi AM,. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650.
41. Wu CC, Lu KC, Chen JS, et al., HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects. Nephrol Dial Transplant 2008; 23: 3082-3090.
42. Kwon KJ, Kim JN, Kim MK, et al., Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuroprotection. J Pineal Res 2011; 50: 110-123.
43. Wang Z, Zhang J, Liu H, et al., Melatonin, a potent regulator of hemeoxygenase-1, reduces cardiopulmonary bypass-induced renal damage in rats. J Pineal Res 2009; 46: 248-254.
44. Lotufo CM, Lopes C, Dubocovich ML, Farsky SH, Markus RP,. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur J Pharmacol 2001; 430: 351-357.